Clinical Trial: A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)

U.S., April 10 -- ClinicalTrials.gov registry received information related to the study (NCT07519395) titled 'A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)' on April 02.

Brief Summary: This study is designed to evaluate the efficacy and safety of camlipixant in adults with IBS-D and IBS-M. The study has two parts. After the first part, some participants will be randomly chosen again to either get a higher dose or stop the drug.

Study Start Date: April 06

Study Type: INTERVENTIONAL

Condition: Irritable Bowel Syndrome

Intervention: DRUG: Placebo

Placebo to be administered

DRUG: Camlipixant

Camlip...